OpenAlex
PricingAboutJobs
Log inGet started
Work

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

HTML

Year: 2010
Type: article
Source: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2010.01.029
Authors: J.E. de Leeuw van Weenen, E.T. Parlevliet, P. Maechler, L.M. Havekes, J.A. Romijn, D.M. Ouwens, H. Pijl, B. Guigas
Institutions: Leiden University Medical Center, University of Geneva, Netherlands Organisation for Applied Scientific Research
Language: English

Topic: Pancreatic function and diabetes
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: bromocriptine, dopamine D2 receptor, alpha2-adrenoceptors, glucose-stimulated insulin secretion, pancreatic beta cells, type 2 diabetes, insulin hypersecretion, beta-cell failure, cAMP signaling, yohimbine, domperidone, hyperglycemic clamp, glucose tolerance test
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2031057942
FWCI: 3.711
Cites: 55
Cited by: 98
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security